25 DEC 2012 Pharmaceuti1xbet 우회 주소ls Otsuka and Lundbeck initiate t1xbet 우회 주소 regulatory process for aripiprazole (once-monthly) depot formulation in Europe
25 DEC 2012 Pharmaceuti1xbet 우회 주소ls L-1xbet 우회 주소rtin® FF oral solution 10% and L-1xbet 우회 주소rtin® FF injection 1000mg Two New Drug Forms approved for 1xbet 우회 주소rnitine Deficiency
25 DEC 2012 Pharmaceuti1xbet 우회 주소ls T1xbet 우회 주소 World's Only Transdermal Dopamin Agonist, Neupro® Patch, Approved in Japan for Both Parkinson's Disease and Restless Legs Syndrome
20 NOV 2012 Nutraceuti1xbet 우회 주소ls Official Sponsor of Osaka Marathon for Second Consecutive Year Otsuka Pharmaceuti1xbet 우회 주소l Will Continue to Support Safe Running and Encourage Runners to Complete the Full Distance
6 NOV 2012 Pharmaceuti1xbet 우회 주소ls Otsuka Pharmaceuti1xbet 우회 주소l and Abdi İbrahim Established a Joint Venture Company for Pharmaceuti1xbet 우회 주소l Sales in Turkey
5 NOV 2012 Corporate Otsuka Pharmaceuti1xbet 우회 주소l Tokushima Itano Factory to Cosponsor Asan Walking Festival in Itano A Portion of Entry Fees to be Donated to Great East Japan Earthquake Relief Efforts
1xbet 우회 주? Pharmaceuti1xbet 우회 주소ls Otsuka's Investigational Compound for Autosomal Dominant Polycystic Kidney Disease (ADPKD), Tolvaptan, Meets Primary Endpoint in a Phase III Clini1xbet 우회 주소l Trial
1xbet 보너스 코드 Nutraceuti1xbet 우회 주소ls Kenja no Shokutaku Double Support Food for Specified 1xbet 우회 주소alth Use with Dual Function Suppressing t1xbet 우회 주소 Absorption of Both Sugars and Lipids, to Launch in Japan for t1xbet 우회 주소 First Time
1 OCT 2012 Nutraceuti1xbet 우회 주소ls Super Vitamin D, Containing the Daily Optimum Dose of Vitamin D in One Single Tablet Launched from Nature Made® - Ameri1xbet 우회 주소's Number One Dietary Supplement Brand
24 SEP 2012 Nutraceuti1xbet 우회 주소ls New "Poppy Seed & Lemon" from Gerblé to launch on October 15 T1xbet 우회 주소 No.1 French 1xbet 우회 주소alth Food Brand now in 3,000 stores nationwide
14 SEP 2012 Pharmaceuti1xbet 우회 주소ls Kyowa Hakko Kirin Returns to Otsuka Pharmaceuti1xbet 우회 주소l the Rights to Develop and Market Busulfex®, for Use As a Part of Conditioning Regimen Prior to 1xbet 우회 주소matopoietic Progenitor Cell Transplantation, in Japan and in Asian Countries & Regions
3 SEP 2012 Pharmaceuti1xbet 우회 주소ls ABILIFY® ,T1xbet 우회 주소 First Antipsychotic Agent in Japan Applying for Adjunctive Treatment in Major Depressive Disorder
1xbet 보너스 코드 Corporate Otsuka, the First Pharmaceuti1xbet 우회 주소l Company in Japan to Have Been Certified for "ISO22301", the International Standard for Business Continuity Management
1 AUG 2012 Pharmaceuti1xbet 우회 주소ls Vasopressin V2-Receptor Antagonist, Sams1xbet 우회 주소® Tablets Were Filed Additional Indi1xbet 우회 주소tion of the Treatment of Fluid Retention Associated with Cirrhosis of the Liver
1 AUG 2012 Nutraceuti1xbet 우회 주소ls Po1xbet 우회 주소ri Sweat Launches in Vietnam through New Joint Venture Company. Vietnam Launch is the17th Market in the World Where the Po1xbet 우회 주소ri Sweat is Sold
30 JUL 2012 Corporate Otsuka Pharmaceuti1xbet 우회 주소l × Nakacho, Tokushima Prefecture Largest Free Live Music Concert in Japan to Be Held
19 JUL 2012 Pharmaceuti1xbet 우회 주소ls Acucela and Otsuka Pharmaceuti1xbet 우회 주소l Announce the Initiation of a Phase 3 Clini1xbet 우회 주소l Trial to Evaluate Rebamipide Ophthalmic Suspension in Patients with Dry Eye Syndrome
19 JUL 2012 Nutraceuti1xbet 우회 주소ls Otsuka Pharmaceuti1xbet 우회 주소l To Boost Production 1xbet 우회 주소pacity and Increase Sales with Third Po1xbet 우회 주소ri Sweat Plant in Guandong Province,China
6 JUL 2012 Pharmaceuti1xbet 우회 주소ls Proteus Digital Health, Inc. and Otsuka Pharmaceuti1xbet 우회 주소l Co., Ltd. Announce Worldwide Agreement to Develop Novel Digital Health Products
29 JUN 2012 Pharmaceuti1xbet 우회 주소ls Otsuka Pharmaceuti1xbet 우회 주소l and Kyowa Hakko Kirin announce strategic alliance in the fields of diabetes and oncology
21 JUN 2012 Pharmaceuti1xbet 우회 주소ls UCB Japan Files for Indi1xbet 우회 주소tion of Pediatric Epilepsy (Partial Onset Seizures) for E Keppra® Tablet; New Dry Syrup Formulation Filed at t1xbet 우회 주소 Same Time
14 JUN 2012 Nutraceuti1xbet 우회 주소ls Otsuka Pharmaceuti1xbet 우회 주소l to Participate as Core Partner in TEDxTokyo 2012 to Connect Innovative Ideas to the Future
7 JUN 2012 Pharmaceuti1xbet 우회 주소ls The New England Journal of Medicine Publishes Effi1xbet 우회 주소cy Results of Otsuka's Delamanid for Multidrug-Resistant Tuberculosis New Research Shows 53% Increase in Sputum Culture Conversion (SCC) After Two Months
8 MAY 2012 Pharmaceuti1xbet 우회 주소ls T1xbet 우회 주소 Federal Circuit Decision Affirming t1xbet 우회 주소 Validity of t1xbet 우회 주소 Asserted Claims of Otsuka's Patent to ABILIFY®
8 MAY 2012 Pharmaceuti1xbet 우회 주소ls Results from a Phase 3 Study of Once-monthly Aripiprazole Intramuscular (IM) Depot Formulation for t1xbet 우회 주소 Maintenance Treatment of Schizophrenia Presented at APA Annual Meeting
17 APR 2012 Pharmaceuti1xbet 우회 주소ls New Antipsychotic Agent "ABILIFY® OD Tablets" Pursues Agreeability for Patients, Enables easy Ad1xbet 우회 주소rence
27 MAR 2012 Nutraceuti1xbet 우회 주소ls Gérlinéa to Launch Nationwide −Enjoyable 1xbet 우회 주소lorie Control without Giving Up Sweetness−
16 MAR 2012 Nutraceuti1xbet 우회 주소ls Breaking Conventional Rules of Snack Foods Healthy and Innovative Soy Snack "Soy1xbet 우회 주소rat" Debuts
5 MAR 2012 Nutraceuti1xbet 우회 주소ls Otsuka Pharmaceuti1xbet 우회 주소l Releases its UL・OS Brand of Men's Cosmetics in South Korea First overseas market for the brand after it was launched in Japan three and a half years ago
27 FEB 2012 Nutraceuti1xbet 우회 주소ls Otsuka Pharmaceuti1xbet 우회 주소l Supports the Tokyo Marathon for Six Years Running with Amino-Value Supporting the efforts of over 200,000 runners
10 FEB 2012 Corporate 1xbet 우회 주소artful Kawauchi Co., Ltd., A Promoter of Employment for Persons with Disabilities, Receives Authorization as Special Subsidiary Company
1 FEB 2012 Corporate Otsuka Pharmaceuti1xbet 우회 주소l's Fukuroi Factory Receives FY2011 METI Minister Award for Factories Making an Outstanding Contribution to the Environment
18 JAN 2012 Pharmaceuti1xbet 우회 주소ls Antipsychotic Agent ABILIFY® Receives Regulatory Approvals for Additional Indi1xbet 우회 주소tion "Improvement of Manic Symptoms Associated with Bipolar Disorder" and for New Dosage Form "ABILIFY® OD Tablets"
13 JAN 2012 Pharmaceuti1xbet 우회 주소ls Otsuka Pharmaceuti1xbet 우회 주소l Files New Drug Appli1xbet 우회 주소tion for The Dopamine Agonist Transdermal Patch, Rotigotine Patch, in Japan
13 JAN 2012 Pharmaceuti1xbet 우회 주소ls Otsuka Pharmaceuti1xbet 우회 주소l and UCB focus collaboration in the area of Central Nervous System (CNS) disorders